Receptors Flashcards
GABAa (11)
involved in chloride inhibition
post synaptic
formed from varying subunits 2a2by
6a subunits, 3b subunits, 3y subunits
BZDs dont work on a4-6 subunits
a5 subunit involved in memory
Binding site between a and y is BZDs
binding site between a and b is agonists/antagonists
channel blockers block the middle of the channel
allosteric modulators (barbiturates) are in the middle of the channel
channel modulators bind to the interior of the channel
GABAb (4)
pre and post synaptic
GPCR linked Gi/Go
K+ cascade
effected by GHB when in high concentrations
GHB (1)
stimulated in low concentrations of barbiturates and increases dopamine and alertness
AMPA (4)
post synoptic
must be activated before NMDA in order to remove Mg++
Glutamate receptors 1-4 are AMPA
ligand gated ion channel
Kainate (4)
pre and post synoptic
must be activated before NMDA in order to remove Mg++
glutamate receptors 5-7 are kainate
K1-2
ligand gated ion channels
NMDA (3)
post synaptic
heterotetrameric structure
ligand gated ion channel
a1 (6)
Gq
NA > A > IA
agonist - phenylephrine and methoxamide
antagonist - prazosine and dozazocine
PLC breaks PIP2 to IP3 and DAG causing Ca+ release
in charge of motor control, cognition and fear
a2 (6)
Gi
A > NA > IA
agonist - clonidine
antagonist - yohimbine and lolazoxan
inhibits sympathetic flow of CNS, decreases cAMP and Ca++ and increases K+
present in all CNS terminals
b1 (6)
Gs
IA > NA > A
agonist - dobutamine
antagonist - atenolol, and metaprolol
increases cAMP
present in cortex, striatum and hippocampus
b2 (6)
Gs
IA > A > NA
agonists - salbutamol, turbutaline, salmeterol and clenbuterol
antagonists - butoxamine
inhibits histamine release from mast cells and increases cAMP
found in the cerebellum
D1 (6)
Gs
agonist - dopamine
partial agonist - apomorphine and bromocryptane
antagonist - clorpromazine, haloperidol and clozapine
involved in reward pathways that produce Euphoria (Sibley 1999)
expressed highly in the cortex, limbic systems and striatum
D2 (6)
Gi/Go
agonist - dopamine, apomorphine and bromocryptane
antagonists - chlorpromazine, haloperidol, spiperone, roclopride
expressed highly in cortex, limbic system, striatum, ventral hypothalamus and anterior pituitary
present in chemoreceptor trigger zone in the medulla associated with N&V
decreased Ach increases K+ and decreases Ca++ which activates pre and post synpatic inhibiton
D3 (5)
Gi/Go
agonist - dopamine, apomorphine and bromocryptane
antagonist - spiperone, haloperidol and clorpromazine
high in limbic system, striatum, ventral hypothalamus and anterior pituitary
decreased Ach increases K+ and decreases Ca++ which activates pre and post synpatic inhibiton
D4 (5)
Gi/Go
agonist - dopamine, apomorphine and bromocryptane
antagonist - haloperidol, spiperone and clozapine
high in limbic system and striatum
decreased Ach increases K+ and decreases Ca++ which activates pre and post synpatic inhibiton
D5 (4)
Gs
high in limbic system and striatum
agonist - dopamine, apomorphine and bromocryptane
antagonist - clorpromazine, haloperidol and clozapine
I1 (2)
receptor for imidazoline
inhibition of sympathetic nervous system to decrease BP
I2 (2)
receptor for imidazoline
allosteric binding site on MAO - psychiatric association
I3 (2)
receptor for imidazoline
insulin secretion regulation
5-HT1 (6)
inhibitory
1A - widely distributed in the limbic system and is the major target for anxiety and depression meds
5-HT1A was found to control feeding behaviour by increasing appetite
1B and 1D - presynaptic inhibitory in the basal ganglia and cortex
5-HT1D antagonist sumatriptan - used for migraines
agonised by Bisporone as a treatment for anxiety
5-HT2 (5)
LSD acts upon it
inhibitory and excitatory by glutamate and GABA balance
2A and 2C - abundant in cortex and limbic system
Barnes + Sharp 1999 found that hallucinations and behavioural changes are by 5-HT2A
5-HT2 receptors have been found to decrease appetite
5-HT3 (4)
ligand gated ion channel (homo/heteromeric, Peters et Al 2005)
present in the area postrema causing vomiting
role of 3A and 3B is known Jensen et Al 2008
antagonised by ondansetron - use as an antiemetic
5-HT4 (3)
present in the limbic system, basal ganglia, hippocampus, substantia nigra
increased cognitive performance by increasing Ach release
receptors oppose respiratory depression actions in opioids
5-HT5 (1)
Baekaert et Al 2006 presented conflicting information on location and function
5-HT6 (2)
present in the hippocampus, cortex and limbic system
are targets for increased cognition and schizophrenia